JMP Securities analyst Constantine Davides maintained a Buy rating on Evolent Health (EVH – Research Report) today and set a price target of ...
In a report released today, David Turkaly from JMP Securities reiterated a Hold rating on Globus Medical (GMED – Research Report). The ...
Rhumbline Advisers boosted its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Free Report) by 2.1% during ...
Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at Wedbush in a research note issued to investors on Friday,RTT News reports.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...
Investors with a lot of money to spend have taken a bullish stance on Reddit RDDT. And retail traders should know. We noticed this today when the trades showed up on publicly available options history ...
On Wednesday, JMP Securities reaffirmed their optimistic stance on Solid Biosciences (NASDAQ:SLDB), maintaining a Market Outperform rating with a steady price target of $15.00. The stock ...
Reddit stock has dropped roughly 23% since its earnings report last week, coming off a six-month rally that saw shares ...
On Tuesday, JMP Securities maintained its Market Outperform rating for Astria Therapeutics (NASDAQ:ATXS) with a steady price target of $26.00, representing significant upside potential from the ...
On Tuesday, JMP Securities maintained its Market Outperform rating for Astria Therapeutics (NASDAQ:ATXS) with a steady price target of $26.00, representing significant upside potential from the ...
The payments company, which is unifying parts of its operation to deepen its reach with consumers and businesses, saw its ...